Stock listing
NASDAQ:XLRN Acceleron Pharma Inc Stock
Follow Acceleron Pharma Inc into a list and get an email when it puts out news.
Last close · NASDAQ:XLRN
$178.75 USD
Close on Nov 22, 2021 · No longer trades
- Lowest – highest close
- $17.40 – $182.78 USDSince Sep 19, 2013 · lowest Nov 7, 2013 · highest Sep 28, 2021
Delisted NASDAQ:XLRN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:XLRN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Acceleron Pharma Inc on 6ix
- Decks
- 13 decks · latest Jun 22, 2021
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Day (June 2021) | Investor day | 139 slides | Jun 22, 2021 |
| ATS 2021 International Conference | Conference | 40 slides | May 19, 2021 |
| J.P. Morgan 39th Annual Healthcare Conference (January 2021) | Conference | 23 slides | Jan 11, 2021 |
| AHA Scientific Sessions 2020 Virtual | Conference | 42 slides | Nov 13, 2020 |
| Technical Presentation (October 2020) | Technical | 31 slides | Oct 2, 2020 |
| Investor Presentation (January 2019) | Investor deck | 39 slides | Jan 7, 2019 |
| ASH 2018 MEDALIST & BELIEVE Phase 3 Trial Presentation call | Conference | 41 slides | Dec 3, 2018 |
| Technical Presentation (December 2018) | Technical | 18 slides | Dec 3, 2018 |
| 60th Annual Meeting of the American Society of Hematology (ASH) 2018 | Conference | 17 slides | Dec 3, 2018 |
| JP Morgan Healthcare Conference 2018 | Conference | 29 slides | Jan 8, 2018 |
All 13 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| 35th Annual J.P. Morgan Healthcare Conference 2017 | Conference | 23 slides | Jan 9, 2017 |
| Investor Day (October 2015) | Investor day | 92 slides | Oct 23, 2015 |
| Investor Presentation (January 2015) | Investor deck | 68 slides | Jan 12, 2015 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Karen Smith Other companies: Context Therapeutics Inc. (Independent Director · Since at least Sep 4, 2024); Skye Bioscience, Inc. (Director · Since at least Jul 2, 2024); Sangamo Therapeutics, Inc. (Director · Since at least Jun 26, 2018); Aurinia Pharmaceuticals Inc (Director · Aug 18, 2023 – Nov 21, 2024 · Past); Quince Therapeutics, Inc. (Chief Medical Officer · May 19, 2022 – Feb 1, 2023 · Past); Tourmaline Bio Inc. (Director · May 16, 2022 – Jun 13, 2023 · Past); Emergent BioSolutions Inc. (EVP, Chief Medical Officer · May 21, 2020 – May 7, 2021 · Past); Antares Pharma Inc (Director · Mar 1, 2019 – May 24, 2022 · Past); Sucampo Pharmaceuticals Inc (Director · Jul 15, 2017 – Feb 13, 2018 · Past); Jazz Pharmaceuticals plc (EVP, R&D and CMO · Apr 13, 2015 – Mar 5, 2018 · Past) | Director · Nov 15, 2017 – Nov 19, 2021 · Past |
| Terrance McGuire Other companies: Tectonic Therapeutic, Inc. (Director · Since at least Jun 20, 2024); Invivyd, Inc. (Director · Since at least Aug 5, 2021); Seer, Inc. (Director · Since at least Dec 3, 2020); Cyclerion Therapeutics, Inc. (Director · Apr 1, 2019 – Nov 30, 2023 · Past); Alector, Inc. (Director · Feb 6, 2019 – Sep 11, 2023 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past); Pulmatrix, Inc. (Director · Jun 15, 2015 – May 16, 2019 · Past); Trevena, Inc. (Director · Jan 30, 2014 – May 14, 2014 · Past); Ironwood Pharmaceuticals, Inc. (Director · Jun 3, 2013 – Apr 1, 2019 · Past) | Director · Sep 18, 2013 – Mar 2, 2017 · Past |
| François Nader Other companies: Tectonic Therapeutic, Inc. (Chair, Board of Directors · Since at least Feb 23, 2026); Moderna, Inc. (Director · Since at least Dec 10, 2019); Tourmaline Bio Inc. (Director · May 6, 2021 – Jun 13, 2023 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Alexion Pharmaceuticals Inc (Director · Nov 15, 2017 – Jul 21, 2021 · Past); Baxalta Inc (Director · Jul 27, 2015 – Jun 3, 2016 · Past); Trevena, Inc. (Director · Jan 30, 2014 – May 20, 2015 · Past); NPS Pharmaceuticals Inc (President, CEO and Director, Director · Apr 8, 2013 – Feb 21, 2015 · Past) | Director · Dec 11, 2014 – Nov 19, 2021 · Past |
| Habib Joseph Dable Other companies: Tyra Biosciences, Inc. (Director · Since at least Apr 16, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Relay Therapeutics, Inc. (Director · Since at least Nov 4, 2025); Day One Biopharmaceuticals Inc (Director · Since at least Jan 17, 2024); PepGen Inc. (Director · Since at least Sep 20, 2022); Blueprint Medicines Corp (Director · Since at least Jun 23, 2022); Jade Biosciences, Inc. (Director · Jul 10, 2023 – Jun 5, 2024 · Past); Albireo Pharma Inc (Director · Aug 8, 2022 – Mar 2, 2023 · Past) | CEO and President, Director · Jan 4, 2021 – Nov 19, 2021 · Past |
| Jean George Other companies: Cyteir Therapeutics Inc (Director · Jun 17, 2021 – Feb 14, 2024 · Past); Disc Medicine, Inc. (Director · Feb 5, 2021 – Feb 5, 2021 · Past); Astria Therapeutics Inc (Director · Jun 24, 2015 – Jun 7, 2018 · Past); Calithera Biosciences, Inc. (Director · Oct 1, 2014 – Jun 11, 2021 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – May 28, 2013 · Past); Zeltiq Aesthetics Inc (Director · Oct 18, 2011 – Jul 22, 2015 · Past) | Director · Sep 18, 2013 – Jan 22, 2020 · Past |
| Kevin F. McLaughlin Other companies: Invivyd, Inc. (Director · Since at least May 21, 2024); Vericel Corporation (Director · Since at least Jan 6, 2015); Decibel Therapeutics Inc (Director · Oct 10, 2022 – Sep 25, 2023 · Past) | SVP, CFO and Treasurer · Jul 7, 2015 – Nov 19, 2021 · Past |
| Richard F. Pops Other companies: Alkermes plc (Director · Since at least Sep 10, 2015); Neurocrine Biosciences, Inc. (Director · Since at least May 28, 2015); Epizyme Inc (Director · Jul 8, 2015 – May 29, 2020 · Past) | Director · Mar 3, 2016 – Jan 25, 2019 · Past |
| Adam Veness Other companies: Dianthus Therapeutics, Inc. (General Counsel · Since at least Sep 11, 2023); Cyteir Therapeutics Inc (General Counsel · Apr 25, 2022 – Feb 3, 2023 · Past) | SVP, General Counsel and Sec. · Jan 4, 2021 – Nov 19, 2021 · Past |
| John Quisel Other companies: Gossamer Bio, Inc. (Director · Since at least Nov 28, 2023); Disc Medicine, Inc. (Chief Executive Officer · Since at least Dec 29, 2022) | EVP, Chief Business Officer · Sep 18, 2013 – Jan 2, 2020 · Past |
| Robert K Zeldin Other companies: MeiraGTx Holdings plc (CHIEF MEDICAL OFFICER · Since at least Aug 3, 2020); Immunovant, Inc. (Chief Medical Officer · Dec 18, 2019 – Dec 18, 2019 · Past) | EVP & Chief Medical Officer · Jun 29, 2018 – Jan 25, 2019 · Past |
All 13 people
| Person | Seat |
|---|---|
| Sujay Kango Other companies: Dianthus Therapeutics, Inc. (Director · Since at least Mar 4, 2025); Lite Strategy, Inc. (Director · Nov 22, 2021 – Sep 29, 2023 · Past) | EVP, Chief Commercial Officer · Feb 12, 2018 – Nov 19, 2021 · Past |
| Kemal Malik Other companies: Cartesian Therapeutics, Inc. (Director · Since at least Jul 1, 2024) | Director · Jan 2, 2020 – Nov 19, 2021 · Past |
| Ravindra Kumar | SVP & Chief Scientific Officer · Oct 6, 2016 – Sep 10, 2019 · Past |
Log in to ask 6ix AI your own questions about Acceleron Pharma Inc.